1,4,4-Trimethyltricyclo[5.3.1.02,6]undecan-11-ol
| Common Name: |
1,4,4-Trimethyltricyclo[5.3.1.02,6]undecan-11-ol |
| IUPAC Name: |
1,4,4-trimethyltricyclo[5.3.1.02,6]undecan-11-ol |
| Molecular Formula: |
C14H24O |
| SMILES: |
CC1(CC2C3CCCC(C2C1)(C3O)C)C |
| Inchi: |
1S/C14H24O/c1-13(2)7-10-9-5-4-6-14(3,12(9)15)11(10)8-13/h9-12,15H,4-8H2,1-3H3 |
| Inchi Key: |
GKUUOBPAWXVPEB-UHFFFAOYSA-N |
| Cas No: |
56747-96-7 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
208.34 |
| Mass (g/mol) |
208.183 |
| Molar Refractivity |
63.71 |
| Net Charge |
|
| HBD |
1 |
| HBA |
1 |
| Rt Bonds |
0 |
| Rings |
3 |
| TPSA |
20.23 |
| Hetero Atoms |
1 |
| Heavy Atoms |
15 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
282.00 to 283.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.00036 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
3.22 |
| iLOGP |
2.92 |
| XLOGP3 |
3.88 |
| WLOGP |
3.22 |
| MLOGP |
3.56 |
| ESOL Log S |
-3.58 |
| ESOL Solubility (mg/ml) |
0.055 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-4.00 |
| Ali Solubility (mg/ml) |
0.02 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-2.58 |
| Silicos-IT Solubility (mg/ml) |
0.55 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-4.82 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.862 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
3.158 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
1 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
1 |
| OCT2 inhibitor |
0 |
